Tyrosine phosphatase SHP-1 in oxidative stress and development of allergic airway inflammation

You Sook Cho1, Sun Young Oh, Zhou Zhu

  • 1Division of Allergy and Clinical Immunology, Johns Hopkins Asthma Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.

Insights

Mice lacking SHP-1 (a protein regulating oxidative stress) showed enhanced allergic airway inflammation. Antioxidants protected against this, suggesting SHP-1

Area of Science:

  • Immunology
  • Cell Biology
  • Respiratory Medicine

Background:

  • Oxidative stress is linked to allergic reactions.
  • SHP-1 protein is affected by oxidants and may control asthma.
  • The role of SHP-1 in allergic airway inflammation under oxidative stress is unclear.

Purpose of the Study:

  • To investigate how oxidative stress affects allergic airway inflammation in mice lacking SHP-1.
  • To explore the function of SHP-1 in lung epithelial cells under oxidative stress.
  • To determine if SHP-1 deficiency breaks immune tolerance to allergens.

Main Methods:

  • Comparison of wild-type (WT) and SHP-1 deficient (mev/+) mice.
  • In vitro studies using human lung epithelial cells (A549) with mutant SHP-1.
  • In vivo and in vitro induction of oxidative stress using hydrogen peroxide and Paraquat.
  • Assessment of immune responses, cell signaling, and inflammatory markers in bronchoalveolar lavage (BAL) and splenocytes.
  • Evaluation of immune tolerance breakdown and therapeutic effects of N-acetylcysteine.

Main Results:

  • Mice lacking SHP-1 exhibited heightened intracellular reactive oxygen species and STAT6 phosphorylation upon oxidant exposure.
  • SHP-1 deficient mice showed increased CCL20, decreased IL-10, and more dendritic cells in BAL fluid.
  • Epithelial cells with mutant SHP-1 secreted more CCL20 and RANTES after oxidative stress.
  • Allergic airway inflammation developed in SHP-1 deficient mice upon allergen exposure, but was reduced by N-acetylcysteine.

Conclusions:

  • SHP-1 plays a crucial role in managing oxidative stress.
  • Increased oxidative stress combined with SHP-1 deficiency may promote allergic airway inflammation.
  • Targeting oxidative stress or enhancing SHP-1 function could be therapeutic strategies for allergic lung diseases.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.8K